Supported by Patient-Centered Clinical Research Coordinating Center funded by the Ministry of Health&Welfare,Republic of Korea(No.HI19C0481,No.HC19C0276).
AIM:To report the first discovery of Ser341Pro myocilin(MYOC)variant in Korea and analyze its clinical characteristics and genetic significance.METHODS:Ten family members from three generations participated in this st...
Supported by the National Natural Science Foundation of China(No.81460093);the Ningxia Nature Science Funding from the Department of Science and Technology of Ningxia Hui Autonomous Region(No.NZ16194)
AIM: To investigate whether the gene variants in MYOC and ABCA1 are associated with primary angle-closure glaucoma(PACG) and anterior chamber depth(ACD) and axial length(AL) in samples from northern China. METHODS: Th...
Background:Pathogenic mechanisms leading to open-angle glaucoma(OAG)are genetically complex.They involve neuroinflammation,elevation of intra-ocular pressures(IOP)and optic nerve hypersensitivity to cellular stresses....
Supported by Natural Science Foundation of China(No.81270999;No.81570870);Professor Academic Development Fund of Fujian Medical University(No.JS14019)
AIM: To identify the mutations of MYOC, OPTN, CYPIB1 and WDR36 in a large Chinese family affected by juvenile open angle glaucoma (JOAG). METHODS: Of 114 members of one family were recruited in this study. Blood ...
National Nature Science Foundation of China (No.81170851)
AIM: To detect the mutations in two candidate genes, myocilin (MYOC ) and cytochrome P450 1B1 (CYP1B1 ), in a Chinese family with primary open angle glaucoma (POAG). ·METHODS:Thefamilywascomposedofthreemembers, the p...